ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewed
HERV-derived epitopes represent new targets for T-cell based immunotherapies in ovarian cancer
Paola Bonaventura, Audrey Page, Olivier Tabone…·Stéphane Depil
This study identifies HERV-derived epitopes as potential targets for T-cell immunotherapies in ovarian cancer, showing their expression in tumors and immunogenicity in patients.
9 citations